Evidence map›Paper›PMID 26342726›Full record

Observational studyJournal of pain and symptom management2016

Methadone Use and the Risk of Hypoglycemia for Inpatients With Cancer Pain.

James H Flory, Alison C Wiesenthal, Howard T Thaler, Lauren Koranteng, Natalie Moryl

Abstract readObservational Study
In one paragraph

Observational study in Journal of pain and symptom management, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
4.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Subcutaneous or intravenous opioid administration by patient-controlled analgesia in cancer pain: a systematic literature review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2019
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Methadone-induced hypoglycemia: A case report.Journal of diabetes investigation · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Pharmacologic Treatment of Opioid Use Disorder: a Review of Pharmacotherapy, Adjuncts, and Toxicity.Journal of medical toxicology : official journal of the American College of Medical Toxicology · 2018
    Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

James H FloryDepartment of Healthcare Policy and Research, Weill Cornell Medical College, New York, New York, USA; Endocrinology Service, Department of Medicine, and Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA. Electronic address: jaf9052@med.cornell.edu.
Alison C WiesenthalPalliative Medicine Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Howard T ThalerEndocrinology Service, Department of Medicine, and Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Lauren KorantengPalliative Medicine Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Natalie MorylPalliative Medicine Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Memorial Sloan Kettering Cancer Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

contextMethadone is an important drug in the management of both cancer-related and non-cancer-related pain and is the main pharmacologic agent used in the treatment of opioid addiction. Unexpected hypoglycemia has been observed in patients receiving methadone, prompting a more detailed investigation.

objectivesTo evaluate the incidence of hypoglycemia in a cohort of inpatients receiving methadone versus other opioids including fentanyl, hydromorphone, and morphine.

methodsRetrospective observational cohort of inpatients in a tertiary cancer center admitted for more than 48 hours from November 1, 2011 to October 30, 2013. The main outcomes were lowest measured daily blood glucose (in mg/dL) and incidence of hypoglycemia (defined as blood glucose < 70 mg/dL, equivalent to 3.9 mmol/L) with variable methadone doses compared with other non-methadone opioids.

resultsOf the 641 eligible patients admitted during the study period who received at least one dose of methadone during admission, multivariable logistic regression showed significant associations between methadone and hypoglycemia at doses greater than 40 mg oral equivalents per day or with patient-controlled analgesia use. A dose-response relationship was observed, with an odds ratio of 3.1 (95% confidence interval 2.5, 3.6) when doses greater than 80 mg/day were used. No evidence of increased risk of hypoglycemia or of a dose-response curve was seen for the other opioids.

conclusionThe risk of hypoglycemia is increased for patients taking more than 40 mg oral methadone equivalents per day. When starting methadone at or more than 40 mg/day, we recommend blood glucose monitoring.

Indexed as

AdultAgedAnalgesics, OpioidBlood GlucoseCancer PainDose-Response Relationship, DrugFemaleHumansHydromorphoneHypoglycemiaIncidenceInpatientsMaleMethadoneMiddle AgedRetrospective StudiesAnalgesics, OpioidBlood GlucoseHydromorphoneMethadoneadverse eventcohort studyhypoglycemiaMethadoneopioid

Identifiers

PMID26342726
PMCPMC5484401
OpenAlexW1541544646

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.